Outcomes of CTAK Surgery
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT07474870
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Corneal Ectasia
- Keratoconus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaire and Physical Exam — BEHAVIORALPatient reported outcomes of CTAK surgery
Study Details
Measuring quality of vision and quality of life outcomes using a validated questionnaire in participants undergoing CTAK surgery for corneal ectasia
Key Dates
- Start date
- May 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2030
- Completion
- Jan 31, 2031
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Patient reported outcomes after CTAK surgeryAll subjects will complete preoperative and postoperative questionnaires
Primary Outcome Measure
Questionnaire [ Time Frame: One year ]
Central Contacts
- Edward Manche, MD16504987020
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Byers Eye Institute at Stanford | Palo Alto | California | 94303 | Edward Manche, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
By research site
Related Studies
- The K-Map Study, Global Prevalence of KCRecruiting · University Hospital, Geneva · Los Angeles, California
- Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal EctasiaPHASE2 · Recruiting · Goodman Eye Center · San Francisco, California
- Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal CrosslinkingPHASE1/PHASE2 · Enrolling By Invitation · Maanasa Indaram, MD · San Francisco, California
- Assessing Patient Engagement in Keratoconus Clinical ResearchNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California